Une nouvelle publication de Vect-Horus dans Pharmaceutics démontre comment les vecteurs peuvent améliorer l’adressage de molécules thérapeutiques vers des organes et tumeurs
22 avr. 2024 09h56 HE
|
Vect-Horus
Marseille, France, 22Avril - VECT-HORUS, l'entreprise de biotechnologie qui conçoit et développe des molécules « vecteurs » qui facilitent l’adressage de molécules thérapeutiques ou d’agents...
Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to Organs and Tumors
22 avr. 2024 09h56 HE
|
Vect-Horus
Marseille, France, April 22 - Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors that facilitate the targeted delivery of therapeutic molecules and imaging...
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development
04 avr. 2024 08h00 HE
|
Biora Therapeutics, Inc.
All pharmacokinetic endpoints were achieved; all NaviCap™ devices performed as intended; no safety signals observed
Global Small Molecule Drug Delivery and Formulation Innovations Report 2024: Disruptive Technologies Drive Growth Opportunities for New Product Launches
04 avr. 2024 05h07 HE
|
Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Innovations in Small Molecule Drug Delivery and Formulation" report has been added to ResearchAndMarkets.com's offering. Small molecules, which are...
Drug-eluting Balloon Catheters Market to Reach USD 1.65 Billion by 2033: Comprehensive Analysis on Trends, Growth Drivers, and Regional Forecast
20 mars 2024 12h26 HE
|
Research and Markets
Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Global Drug-eluting Balloon Catheters Market Analysis & Forecast to 2023-2033: Market By Drug; By Indication; By End User; and By Region" report...
Global Drug Eluting Stents Market to Reach $13.2 Billion by 2030, Driven by the Rise in Minimally Invasive Procedures
19 mars 2024 13h36 HE
|
Research and Markets
Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "Global Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report by Application (Coronary Artery Disease, and Peripheral Artery...
NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit
01 mars 2024 16h04 HE
|
NurExone Biologic Inc
NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit
Long-Acting Drug Delivery Technologies and Services Market Predicted to Reach $36.82 Billion by 2033, as Asia-Pacific Emerges with Highest CAGR
28 févr. 2024 09h56 HE
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Long-Acting Drug Delivery Technologies and Services Market: A Global and Regional Analysis, 2023-2033" report has been added to ...
NurExone’s Intellectual Property Portfolio Expands
20 févr. 2024 16h05 HE
|
NurExone Biologic Inc
NurExone's Intellectual Property portfolio is expanding to encompass processes and compositions related to exosomes in large-scale production
Advanced Drug Delivery Systems Market Sees Promising Growth, New Technological Advancements Driving Industry Forward
25 janv. 2024 20h35 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Global Advanced Drug Delivery Systems Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global advanced drug delivery...